166TiP Pembrolizumab combined with neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy followed surgery for locally advanced esophageal squamous cell carcinoma: Protocol for a multi-center, prospective, randomized-controlled, phase III clinical study (Keystone-002)
Year: 2021
Type: article
Study design: Study Protocol
Source: Annals of Oncology
Institutions: Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin Medical University General Hospital, Affiliated Hospital of Qingdao University, Liaoning Cancer Hospital & Institute, Shandong Provincial Hospital, Shandong First Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4200600751
